These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 20816410)

  • 1. Pharmacology.
    Bolay H; Durham P
    Handb Clin Neurol; 2010; 97():47-71. PubMed ID: 20816410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute treatment of migraine.
    Brandes JL; Buchanan TM; Welch KM
    Handb Clin Neurol; 2010; 97():323-36. PubMed ID: 20816432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute management of migraine.
    Chowdhury D
    J Assoc Physicians India; 2010 Apr; 58 Suppl():21-5. PubMed ID: 21049703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical considerations for the treatment of elderly patients with migraine.
    Sarchielli P; Mancini ML; Calabresi P
    Drugs Aging; 2006; 23(6):461-89. PubMed ID: 16872231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptans: over the migraine.
    Cologno D; Mazzeo A; Lecce B; Mundi C; Petretta V; Casucci G; d'Onofrio F
    Neurol Sci; 2012 May; 33 Suppl 1():S193-8. PubMed ID: 22644202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of new acute treatments for migraine.
    Lupi C; Benemei S; Guerzoni S; Pellesi L; Negro A
    Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):189-198. PubMed ID: 30714429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?
    Neeb L; Meents J; Reuter U
    Neurotherapeutics; 2010 Apr; 7(2):176-82. PubMed ID: 20430316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the 5-HT
    Huang PC; Yang FC; Chang CM; Yang CP
    Prog Brain Res; 2020; 255():99-121. PubMed ID: 33008517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.
    Thorlund K; Mills EJ; Wu P; Ramos E; Chatterjee A; Druyts E; Goadsby PJ
    Cephalalgia; 2014 Apr; 34(4):258-67. PubMed ID: 24108308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological strategies to treat attacks of episodic migraine in adults.
    Tfelt-Hansen P
    Expert Opin Pharmacother; 2021 Feb; 22(3):305-316. PubMed ID: 33003955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Migraine Treatment in Adults.
    Becker WJ
    Headache; 2015 Jun; 55(6):778-93. PubMed ID: 25877672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in pharmacological treatment of migraine.
    Diener HC; Limmroth V
    Expert Opin Investig Drugs; 2001 Oct; 10(10):1831-45. PubMed ID: 11772289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the acute migraine headache.
    Aukerman G; Knutson D; Miser WF;
    Am Fam Physician; 2002 Dec; 66(11):2123-30. PubMed ID: 12484694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative tolerability of treatments for acute migraine: A network meta-analysis.
    Thorlund K; Toor K; Wu P; Chan K; Druyts E; Ramos E; Bhambri R; Donnet A; Stark R; Goadsby PJ
    Cephalalgia; 2017 Sep; 37(10):965-978. PubMed ID: 27521843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the safety and tolerability profile of acute treatments for migraine.
    Martin VT; Goldstein JA
    Am J Med; 2005 Mar; 118 Suppl 1():36S-44S. PubMed ID: 15841886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptor ligands: treatments of acute migraine and cluster headache.
    Goadsby PJ
    Handb Exp Pharmacol; 2007; (177):129-43. PubMed ID: 17087122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine: pathophysiology, pharmacology, treatment and future trends.
    Villalón CM; Centurión D; Valdivia LF; de Vries P; Saxena PR
    Curr Vasc Pharmacol; 2003 Mar; 1(1):71-84. PubMed ID: 15320857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of the 5-HT1B/1D receptor agonists.
    Tepper SJ; Rapoport AM; Sheftell FD
    Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.